Patients with heart disease should aim to be physically active seven minutes for every 20 they’re sedentary to prolong life and prevent further cardiovascular damage, according to research presented at the 2018 Canadian Cardiovascular Congress in Toronto.

A novel risk score incorporating patient demographics and clinical characteristics known ahead of hospital discharge can accurately identify CVD patients at low and high risk for 90-day readmission after an initial acute MI (AMI), according to research published in the October edition of Circulation: Cardiovascular Quality and Outcomes.

A point-of-care troponin assay that yields results within about 15 minutes was equally effective at ruling out acute myocardial infarction (AMI) as a high-sensitivity troponin I test performed in a laboratory setting, researchers reported in JAMA Cardiology.

Cystatin C (Cys-C), an alternative to renal markers like creatinine and glomerular filtration rate, can effectively predict a patient’s risk for adverse CVD events after an acute coronary syndrome (ACS), researchers reported Oct. 12 in the Journal of the American Heart Association.

A study presented at TCT 2018 questioned the benefits of “drip-and-ship” for elderly patients with ST-segment elevation myocardial infarction (STEMI), finding patients in their 80s or older who were transferred with fibrinolytic therapy for PCI had an eight-fold risk of hemorrhagic stroke but no survival advantage.

Fewer than one-third of Chinese patients with acute coronary syndromes (ACS) receive guidance to participate in cardiac rehabilitation, according to research presented Oct. 11 at the Great Wall International Congress of Cardiology.

People with unrecognized myocardial infarction carry a lower short-term risk of death but an equal 10-year risk of mortality compared to those with clinically diagnosed heart attacks, according to an analysis of the ICELAND MI study published in JAMA Cardiology.

A genomic risk prediction tool developed by researchers in Australia and the U.K. has achieved greater risk discrimination than its predecessors while identifying patients at the highest and lowest likelihood of developing coronary artery disease (CAD), according to a study published ahead of print in the Journal of the American College of Cardiology.